{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:49:42Z","timestamp":1761893382513,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational and Theoretical Chemistry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.comptc.2021.113375","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T02:40:30Z","timestamp":1626489630000},"page":"113375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Preliminary investigation of drug impurities associated with the anti-influenza drug Favipiravir \u2013 An insilico approach"],"prefix":"10.1016","volume":"1204","author":[{"given":"S.","family":"Anil Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.L.","family":"Bhaskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.comptc.2021.113375_b0005","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.mjafi.2020.08.004","article-title":"Favipiravir: A new and emerging antiviral option in COVID-19","volume":"76","author":"Agrawal","year":"2020","journal-title":"Med. J. Armed Forces, India"},{"key":"10.1016\/j.comptc.2021.113375_b0010","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.comptc.2021.113375_b0015","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1002\/asia.201900841","article-title":"New nucleoside analogues for the treatment of hemorrhagic fever virus infections","volume":"14","author":"Clercq","year":"2019","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.comptc.2021.113375_b0020","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1073\/pnas.0909603107","article-title":"T-705 (favipiravir) activity against lethal H5N1 influenza A viruses","volume":"107","author":"Kiso","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.comptc.2021.113375_b0025","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/AAC.01051-06","article-title":"Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice","volume":"51","author":"Sidwell","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"54","key":"10.1016\/j.comptc.2021.113375_b0030","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/AAC.01739-09","article-title":"In-vitro antiviral activity of favipiravir (T-705) against drugresistant influenza and 2009 A(H1N1) viruses","volume":"2010","author":"Sleeman","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.comptc.2021.113375_b0035","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/07853890.2021.1875500","article-title":"Efficacy of the current investigational drugs for the treatment of COVID-19: a scoping review","volume":"53","author":"Wadaa-Allah","year":"2021","journal-title":"Ann. Med."},{"issue":"10","key":"10.1016\/j.comptc.2021.113375_b0040","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.eng.2020.03.007","article-title":"Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study","volume":"6","author":"Cai","year":"2020","journal-title":"Engineering"},{"key":"10.1016\/j.comptc.2021.113375_b0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"issue":"8","key":"10.1016\/j.comptc.2021.113375_b0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00214-020-02656-2","article-title":"Favipiravir tautomerism: a theoretical insight","volume":"139","author":"Antonov","year":"2020","journal-title":"Theor. Chem. Acc."},{"issue":"3","key":"10.1016\/j.comptc.2021.113375_b0055","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of Action of T-705 against Influenza Virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.comptc.2021.113375_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111313","article-title":"An update review of emerging small-molecule therapeutic options for COVID-19","volume":"137","author":"Tian","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.comptc.2021.113375_b0065","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2015.07.003","article-title":"Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever","volume":"121","author":"Gowen","year":"2015","journal-title":"Antivir Res."},{"issue":"12","key":"10.1016\/j.comptc.2021.113375_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006034","article-title":"QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient","volume":"11","author":"Chinello","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.comptc.2021.113375_b0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S2055-6640(20)30016-9","article-title":"A review of the safety of Favipiravir \u2013 a potential treatment in the COVID-19 pandemic?","volume":"6","author":"Pilkington","year":"2020","journal-title":"J. Virus Erad."},{"key":"10.1016\/j.comptc.2021.113375_b0080","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1021\/acs.oprd.0c00233","article-title":"Quest for a covid-19 cure by repurposing small-molecule drugs: mechanism of action, clinical development, synthesis at scale, and outlook for supply","volume":"24","author":"De Savi","year":"2020","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.comptc.2021.113375_b0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1620\/tjem.251.87","article-title":"Uric acid elevation by Favipiravir, an antiviral drug","volume":"251","author":"Mishima","year":"2020","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.comptc.2021.113375_b0090","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Furutaa","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.comptc.2021.113375_b0095","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s00705-017-3436-8","article-title":"Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication","volume":"162","author":"Cai","year":"2017","journal-title":"Arch. Virol."},{"key":"10.1016\/j.comptc.2021.113375_b0100","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/cmdc.201700116","article-title":"Synthesis of T-705-ribonucleoside and T-705-ribonucleotide and studies of chemical stability","volume":"12","author":"Huchting","year":"2017","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.comptc.2021.113375_b0105","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1021\/acs.jmedchem.8b00617","article-title":"Prodrugs of the phosphoribosylated forms of hydroxypyrazinecarboxamide pseudobase T-705 and its de-fluoro analogue T-1105 as potent influenza virus inhibitors","volume":"61","author":"Huchting","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.comptc.2021.113375_b0110","unstructured":"M.J. Frisch, G.W. Trucks, H.B. Schlegel, Gaussian, Inc., Wallingford, CT, 2009."},{"issue":"42717","key":"10.1016\/j.comptc.2021.113375_b0115","first-page":"1","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Nature Sci. Rep."},{"issue":"11","key":"10.1016\/j.comptc.2021.113375_b0120","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.comptc.2021.113375_b0125","article-title":"M. Electronic, thermoelectric, transport and optical properties of MoSe2\/BAs van der Waals heterostructures","volume":"23","author":"Yi","year":"2021","journal-title":"Results Phys."},{"key":"10.1016\/j.comptc.2021.113375_b0130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jps.2600710611","article-title":"Use of dipole moment as a parameter in drug-receptor interaction and quantitative structure-activity relationship studies","volume":"71","author":"Lien","year":"1982","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.comptc.2021.113375_b0135","doi-asserted-by":"crossref","first-page":"9993","DOI":"10.1039\/C5OB01565K","article-title":"The effect of N-methylation of amino acids (Ac-X-OMe) on solubility and conformation: a DFT study","volume":"13","author":"Rauf","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.comptc.2021.113375_b0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.molstruc.2015.02.076","article-title":"Theoretical analysis (NBO, NPA, Mulliken Population Method) and molecular orbital studies (hardness, chemical potential, electrophilicity and Fukui function analysis) of (E)-2-((4-hydroxy-2-methylphenylimino)methyl)-3-methoxyphenol","volume":"1091","author":"Demircioglu","year":"2015","journal-title":"J. Mole. Struct."},{"key":"10.1016\/j.comptc.2021.113375_b0145","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.3390\/ijms21113922","article-title":"Investigation of some antiviral n-heterocycles as covid 19 drug: molecular docking and DFT calculations","volume":"21","author":"Hagar","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.comptc.2021.113375_b0150","article-title":"Structural elucidation of antihemorrhage drug molecule Diethylammonium 2,5-dihydroxybenzene sulfonate - An insilico approach","volume":"310","author":"Kumar","year":"2018","journal-title":"IOP Conf. Ser.: Mater. Sci. Eng."},{"key":"10.1016\/j.comptc.2021.113375_b0155","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.14233\/ajchem.2015.19068","article-title":"Computational and spetral studies of Nimesulide impurity D: 4Nitro 2-Phenoxy aniline","volume":"27","author":"Kumar","year":"2015","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.comptc.2021.113375_b0160","first-page":"23","article-title":"Identification of potential nematicidal compounds against the pine wood nematode, bursaphelenchus xylophilus through an in silco approach","volume":"2018","author":"Shanmugam","year":"1828","journal-title":"Molecules"},{"key":"10.1016\/j.comptc.2021.113375_b0165","article-title":"Theoretical investigation of the derivatives of favipiravir (T-705) as potential drugs for Ebola virus","volume":"3","author":"Rhyman","year":"2018","journal-title":"Phys. Sci. Rev."},{"key":"10.1016\/j.comptc.2021.113375_b0170","article-title":"Spectroscopic and computational approach for the structure-property relationship of hydantoin drug impurity: 1-methyl-5,5-diphenylimidazolidine-2, 4-dione","volume":"577","author":"Kumar","year":"2019","journal-title":"IOP Conf. Ser. Mater. Sci. Eng."},{"issue":"5(9)","key":"10.1016\/j.comptc.2021.113375_b0175","doi-asserted-by":"crossref","first-page":"e02420","DOI":"10.1016\/j.heliyon.2019.e02420","article-title":"Computational and spectral studies of 3, 3'-(propane-1,3-diyl)bis(7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one)","volume":"30","author":"Kumar","year":"2019","journal-title":"Heliyon"}],"container-title":["Computational and Theoretical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210271X21002334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210271X21002334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:58:23Z","timestamp":1761886703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210271X21002334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":35,"alternative-id":["S2210271X21002334"],"URL":"https:\/\/doi.org\/10.1016\/j.comptc.2021.113375","relation":{},"ISSN":["2210-271X"],"issn-type":[{"type":"print","value":"2210-271X"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preliminary investigation of drug impurities associated with the anti-influenza drug Favipiravir \u2013 An insilico approach","name":"articletitle","label":"Article Title"},{"value":"Computational and Theoretical Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.comptc.2021.113375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113375"}}